Unknown

Dataset Information

0

Blood-borne miRNA profile-based diagnostic classifier for lung adenocarcinoma.


ABSTRACT: Accumulated evidence indicates that various types of miRNA are aberrantly expressed in lung cancer and secreted into the bloodstream. For this study, we constructed a serum diagnostic classifier based on detailed bioinformatics analysis of miRNA profiles from a training cohort of 143 lung adenocarcinoma patients and 49 healthy subjects, resulting in a 20 miRNA-based classifier. Validation performed with an independent cohort of samples from lung adenocarcinoma patients (n?=?110), healthy subjects (n?=?52), and benign pulmonary disease patients (n?=?47) showed a sensitivity of 89.1% and specificity of 94.9%, with an area under the curve value of 0.958. Notably, 90.8% of Stage I lung adenocarcinoma cases were correctly diagnosed. Interestingly, this classifier also detected squamous and large cell lung carcinoma cases at relatively high rates (70.4% and 70.0%, respectively), which appears to be consistent with organ site-dependent miRNA expression in cancer tissues. In contrast, we observed significantly lower rates (0-35%) using samples from 96 cases of cancer in other major organs, with breast cancer the lowest. These findings warrant a future study to realize its clinical application as a part of diagnostic procedures for lung cancers, for which early detection and surgical removal is presently the only hope for eventual cure.

SUBMITTER: Tai MC 

PROVIDER: S-EPMC4979017 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


Accumulated evidence indicates that various types of miRNA are aberrantly expressed in lung cancer and secreted into the bloodstream. For this study, we constructed a serum diagnostic classifier based on detailed bioinformatics analysis of miRNA profiles from a training cohort of 143 lung adenocarcinoma patients and 49 healthy subjects, resulting in a 20 miRNA-based classifier. Validation performed with an independent cohort of samples from lung adenocarcinoma patients (n = 110), healthy subject  ...[more]

Similar Datasets

| S-EPMC5041965 | biostudies-literature
| S-EPMC10585112 | biostudies-literature
| S-EPMC5975616 | biostudies-literature
| S-EPMC5126285 | biostudies-literature
2023-10-31 | GSE240757 | GEO
2023-10-31 | GSE240759 | GEO
| S-EPMC7531016 | biostudies-literature
| S-EPMC10163250 | biostudies-literature
| S-EPMC6325795 | biostudies-literature